???global.info.a_carregar???
Mónica Cerqueira holds a degree in Biochemistry from the University of Minho (2019) and a Master's degree in Health Sciences, at the School of Medicine - University of Minho (EM-UMinho), with a final grade of 19 (out of 20) on the thesis project. During this last academic year, Mónica was a researcher at the Life and Health Sciences Research Institute (ICVS), EM-UMinho, and at the International Iberian Nanotechnology Laboratory (INL). The main focus of her master thesis was the full pre-clinical validation (in vitro and in vivo) of a novel biocompatible theranostic probe activated in the tumor site, through a magnetic field. This work had financial support from the Foundation for Science and Technology (FCT) - project PTDC/BTM-SAL/31142/2017. Mónica is a researcher at the ICVS, focusing her interest on the study of novel synthetic molecules as targeted agents against triple-negative breast cancer and renal cell carcinoma. Since September of 2022, she is a PhD student in the doctoral program of Health Sciences in University of Minho, being awarded with a PhD grant from FCT. During her academic path, Mónica published 1 review article (IF=6.321, Q1) as the first author and presented several conference posters at national and international scientific congresses, and a oral comunication at national congress.
Read full resume ↓
Identification

Personal identification

Full name
Mónica Alexandra da Costa Cerqueira
Date of birth
1998/03/22
Gender
Female

Citation names

  • Cerqueira, Mónica

Author identifiers

Ciência ID
7D1C-C417-CF6A
ORCID iD
0000-0002-8167-4140

Email addresses

  • monicaalexandra22@hotmail.com (Professional)

Addresses

  • Campus de Gualtar, University of Minho, 4710-057, Gualtar, Braga, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Health Sciences
  • Medical and Health Sciences - Clinical Medicine - Oncology
  • Natural sciences - Biological Sciences - Biochemistry
  • Natural sciences - Biological Sciences - Molecular Biology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Proficiency (C2) Advanced (C1) Proficiency (C2)
French Beginner (A1) Elementary (A2) Beginner (A1) Elementary (A2)
Education
Degree Classification
2022/09/01 - 2027
Ongoing
 PhD in Health Sciences (Doutoramento)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2019/09/01 - 2022/02/09
Concluded
 Ciências da Saúde (Mestrado)
Major in Oncologia
Universidade do Minho, Portugal
"Treatment of triple-negative breast cancer (TNBC) through externally triggered targetless drug carriers" (THESIS/DISSERTATION)
 Thesis: 19; Master's degree: 18 (ou of 20)
2020/04 - 2020/05
Concluded
 Laboratory Animal Science (Curso de mestrado (conclusão do curso de especialização))
Universidade do Minho, Portugal
 17 (out of 20)
2020/01 - 2020/02
Concluded
 Biostatistics in Health Sciences (Curso de mestrado (conclusão do curso de especialização))
Universidade do Minho Escola de Medicina, Portugal
 16 (out of 20)
2019/09 - 2019/10
Concluded
 Fundamentals of Genetics, Development and Neoplasia (Curso de mestrado (conclusão do curso de especialização))
Universidade do Minho Escola de Medicina, Portugal
 16 (out of 20)
2016/09/01 - 2019/07/01
Concluded
 Bioquímica (Licenciatura)
Universidade do Minho, Portugal
"Gene expression dynamics of monoterpene catabolic modules in Pseudomonas sp." (THESIS/DISSERTATION)
 15 (out of 20)
Affiliation

Science

Category
Host institution 		Employer
2020/07 - Current Researcher (Research) Laboratório Associado ICVS 3B's, Portugal
2020/07 - 2022/02 Researcher (Research) Laboratório Internacional Ibérico de Nanotecnologia, Portugal
2019/01 - 2019/07 Research Trainee (Research) Universidade do Minho, Portugal

Others

Category
Host institution 		Employer
2019/11 - 2020/03 Laboratory internship Laboratório Associado ICVS 3B's, Portugal
Projects

Grant

Designation Funders
2022/09/01 - Current Exploitation of a novel drug candidate for renal cell carcinoma therapy
2022.10233.BD
PhD Student Fellow
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing

Contract

Designation Funders
2020/05 - 2022/02 Local specific treatment of triple-negative-breast-cancer through externally triggered target-less drug carriers
PTDC/BTM-SAL/31142/2017
Researcher
International Iberian Nanotechnology Laboratory, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
Fundação para a Ciência e a Tecnologia

European Regional Development Fund
Concluded
Outputs

Publications

Conference poster
  1. Carvalho, Luísa; Pedroso de Lima, Fábio; Cerqueira, Mónica; Silva, Ana; Pontes, Olívia; Oliveira-Pinto, Sofia; Guerreira, Sara; et al. Corresponding author: Costa, Marta. "Biological characterization of novel chromeno[2,3-d]pyrimidinones as therapeutic approach for the treatment of triple-negative Breast Cancer". Paper presented in III ASPIC-ASEICA International Meeting Abstract Submission, 2023.
  2. Costa, Marta; Cerqueira, Mónica; Silva, Ana; Pontes, Olívia; Oliveira-Pinto, Sofia; Carvalho, Luísa; Lopes, Diogo; et al. "Chromene-based molecules: privileged scaffold for oncology drug development". Paper presented in III ASPIC-ASEICA International Meeting Abstract Submission, 2023.
  3. Silva, Ana; Félix, Ana; Cerqueira, Mónica; Gonçalves, Céline S.; Longatto, Adhemar; Baltazar, Fátima; Afonso, Julieta. "Effects of lactate transport inhibition by AZD3965 in muscle-invasive urothelial bladder cancer". Paper presented in III ASPIC-ASEICA International Meeting Abstract Submission, 2023.
  4. Carvalho, Luísa; Pedroso de Lima, Fábio; Cerqueira, Mónica; Silva. Ana; Pontes, Olívia; Oliveira-Pinto, Sofia; Guerreiro, Sara; et al. Corresponding author: Costa, Marta. "In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer". Paper presented in 5th National Meeting for Young Researchers in Oncology, 2023.
  5. Carvalho, Luísa; Pedroso de Lima, Fábio; Cerqueira, Mónica; Silva. Ana; Pontes, Olívia; Oliveira-Pinto, Sofia; Guerreiro, Sara; et al. Corresponding author: Costa, Marta. "Avaliação in vitro e in vivo de novos cromeno[2,3-d]pirimidinonas como agentes terapêuticos para o cancro da mama triplo-negativo". Paper presented in 5th National Meeting for Young Researchers in Oncology, 2023.
  6. Cerqueira, Mónica; Belmonte-Reche, Efres; Gonçalves, Céline; Costa, Marta; Rainha, Raquel; Silva, Ana; Gallo, Juan; Baltazar, Fátima; Bañobre, Manuel. "Treatment of triple-negative breast cancer through externally triggered target-less drug carriers". Paper presented in XXIX PORTO CANCER MEETING - Glycosylation in tumour biology and its clinical implications, 2023.
  7. Silva, Ana; Cerqueira, Mónica; Rosa, Beatriz; Sobral, Catarina; Pinto-Ribeiro, Filipa; Costa, Marta; Baltazar, Fátima; Afonso, Julieta. "Prognostic value of monocarboxylate transporter 1 overexpression in cancer: a systematic review". Paper presented in XXIX PORTO CANCER MEETING - Glycosylation in tumour biology and its clinical implications, 2023.
  8. Cerqueira, Mónica; Belmonte-Reche, Efres; Costa, Marta; Baltazar, Fátima; Gallo, Juan; Bañobre-López, Manuel. "In vitro validation of a new magnetic solid lipid nanoformulation against Triple-Negative Breast Cancer". Paper presented in II ASPIC-ASEICA International Meeting – Current Trends in Precision Medicine in Cancer, 2021.
  9. Cerqueira, Mónica; Belmonte-Reche, Efres; Costa, Marta; Baltazar, Fátima; Gallo, Juan; Bañobre-López, Manuel. "Validação de uma nova nanoformulação direcionada para o diagnóstico e tratamento do cancro da mama triplo-negativo". Paper presented in 3º Encontro nacional de Jovens Investigadores em Oncologia, 2021.
  10. Cerqueira, Mónica; Belmonte-Reche, Efres; Costa, Marta; Baltazar, Fátima; Gallo, Juan; Bañobre-López, Manuel. "In vitro validation of new theranostic nanoformulation against Triple-negative breast cancer". Paper presented in 27th Porto Cancer Meeting, 2021.
  11. Cerqueira, Mónica; Belmonte-Reche, Efres; Costa, Marta; Baltazar, Fátima; Gallo, Juan; Bañobre-López, Manuel. "In vitro validation of a new magnetic formulation against Trile-negative breast cancer". Paper presented in EuroNanoForum 2021, 2021.
Journal article
  1. Ana Silva; Ana Félix; Mónica Cerqueira; Céline S. Gonçalves; Belém Sampaio-Marques; Adhemar Longatto-Filho; Fátima Baltazar; Julieta Afonso. "Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer". Pharmaceutics (2023): https://doi.org/10.3390/pharmaceutics15122688.
    10.3390/pharmaceutics15122688
  2. Ana Silva; Cerqueira, Mónica; Beatriz Rosa; Catarina Sobral; Filipa Pinto-Ribeiro; Marta Freitas Costa; Fátima Baltazar; Julieta Afonso. Corresponding author: Fátima Baltazar. "Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review". International Journal of Molecular Sciences 24 6 (2023): 5141. https://doi.org/10.3390/ijms24065141.
    Open access • Published • 10.3390/ijms24065141
  3. Luísa Carvalho; Pedroso de Lima, Fábio; Pontes, Olívia; Oliveira-Pinto, Sofia; Cerqueira, Mónica; Ana silva; Guerreiro, Sara R.; et al. "Synthesis and Biological Evaluation of Novel Chromeno[2,3-d]Pyrimidinones as Agents for Triple Negative Breast Cancer Treatment". RSC Medicinal Chemistry (2023):
    Under revision
  4. Cerqueira, Mónica; Belmonte-Reche, Efres; Gallo, Juan; Baltazar, Fátima; Bañobre-López, Manuel. "Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics". Pharmaceutics 14 3 (2022): 506. http://dx.doi.org/10.3390/pharmaceutics14030506.
    Published • 10.3390/pharmaceutics14030506
Thesis / Dissertation
  1. "Treatment of triple-negative breast cancer using externally activated solid-lipid nanoparticles". Master, Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, 2022.
  2. "Gene expression dynamics of monoterpene catabolic modules in Pseudomonas sp.". Degree, Universidade do Minho Escola de Ciências, 2019.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2023/09 Avaliação in vitro e in vivo de novos cromeno[2,3-d]pirimidinonas como agentes terapêuticos para o cancro da mama triplo-negativo 5th National Meeting for Young Researchers in Oncology
Portuguese League Against Cancer (LPCC-NRN) (Porto, Portugal)
2022/09/24 Treatment of triple-negative breast cancer using externally activated solid-lipid nanoparticles 4th National Meeting of Young Researcher in Oncology
Portuguese League Against Cancer (LPCC-NRN) (Porto, Portugal)

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2023/05/06 - 2023/05/06 Human Book - researcher in cancer: round table discussion with high school students about cancer (awareness, risk factors and prevention)
Round table
 Human Library - Cancer
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2021/10/14 - 2021/10/15 II ASPIC-ASEICA International Meeting: Virtual Congress
Congress
 II ASPIC-ASEICA International Meeting: Current Trends in Precision Medicine in Cancer
European Association For Cancer Research, United Kingdom
2021/09/24 - 2021/09/24 Encontro nacional de Jovens Investigadores em Oncologia: Virtual Congress
Congress
 3º Encontro nacional de Jovens Investigadores em Oncologia
Liga Portuguesa Contra o Cancro, Portugal
2021/05/20 - 2021/05/21 27th Porto Cancer Meeting: Virtual congress
Congress
 27th Porto Cancer Meeting
Universidade do Porto, Portugal
2021/05/05 - 2021/05/06 EuroNanoForum 2021: Virtual Congress
Congress
 EuroNanoForum 2021
International Iberian Nanotechnology Laboratory, Portugal

Association member

Society Organization name Role
2020/01 - Current Portuguese League Against Cancer - Liga Portuguesa Contra o Cancro Member
2020/01 - Current European Association for Cancer Research (EARC) through the Portuguese Association for Cancer Research (ASPIC) Member
2020/01 - Current Portuguese Association for Cancer Research - ASPIC Member

Mentoring / Tutoring

Topic Student name
2022/10/01 - 2033/03/29 BVZ-nanoparticles for the treatment of colorectal cancer Alice Leão
2022/11/01 - 2033/03/10 Synthesis of chromene-based compounds and characterization of their anticancer activity in bladder cancer cells Diana Araújo
2022/10/01 - 2023/02/16 Novel potent, effective, and safe chromene based compounds for the treatment of Triple-Negative Breast Cancer Luis Fernandes
Distinctions

Award

2022 Best Oral Communication Award
4th National Meeting of Young Researcher in Oncology - Portuguese League Against Cancer (LPCC-NRN), Portugal